Robinson PLC - Chesterfield, Derbyshire-based manufacturer of plastic and paperboard packaging - Announces the sale of Cannon Mill, part of the Wheatbridge site, to Middleton Structures Ltd with ...

Both firms are UK-based student accommodation providers. The acquisition was approved at a court and general meeting on Monday. Just under 71% of votes in the court meeting gave the deal the green ...

(Alliance News) - Shares in Mondi PLC on Monday tumbled after posting a "shocker" third-quarter operational performance. The Weybridge, England-based packaging firm shed 16% to 879.60 pence in London, ...

Genedrive added that "it did not receive any expressions of interest from potential acquirers". The firm said the placing extends its cash runway through to the end of 2025. However, should the ...

In European equities on Monday, the CAC 40 in Paris closed down 1.4%, while the DAX 40 in Frankfurt ended unchanged. The CAC 40 tumbled after Prime Minister Sebastien Lecornu resigned.

On Monday last week, Beacon Rise said entered non-binding heads of terms to acquire Ergotec for approximately GBP1.0 million. At this time, Beacon Rise said it was preliminary discussions with regard ...

(Alliance News) - Ananda Pharma PLC on Monday said the last patient has received their final MRX1 dose in the phase one pharmacokinetic study. Ananda is a London-based biopharmaceutical company that ...

Aeorema Communications PLC - London-based live events agency - Aeorema's Cheerful Twentyfirst brand experience agency has seen "consistent and continued momentum" in North America over the past three ...

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: SkinBioTherapeutics PLC - life science firm focused on skin health - ...

Fulcrum has been issued with 78.7 million common shares in Loyalist, as well as CAD500,000 in cash, which is about GBP266,344, and a 2.0% net smelter return royalty on the Tully project.

(Alliance News) - tinyBuild Inc on Monday maintained it was "is on track to deliver results at least in line with expectations," whilst noting its recent share price movement. The Seattle, ...

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment.